Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia
Areej El‐Jawahri(Massachusetts General Hospital), Jennifer S. Temel(Harvard University), Amir T. Fathi(Massachusetts General Hospital), Showly Nicholson(Harvard University), Selina M. Luger(University of Pennsylvania), Jillian Gustin(The Ohio State University), Bhavana Bhatnagar(The Ohio State University), Nina O’Connor(University of Pennsylvania), Alison R. Kavanaugh(Harvard University), Jason A. Webb(Duke University), Joseph A. Greer(Harvard University), Toby C. Campbell(University of Wisconsin–Madison), Gabriela Hobbs(Massachusetts General Hospital), Hilena Addis(Duke University), Nora Horick(Massachusetts General Hospital), Dagny Vaughn(Massachusetts General Hospital), Thomas W. LeBlanc(Duke University), Alison R. Walker(The Ohio State University), D. Davis(Duke University), Ellin Gafford(The Ohio State University), Vicki A. Jackson(Johns Hopkins University), Andrew M. Brunner(Massachusetts General Hospital)
Cited by 174
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907